DAFDA, A.; SINGH, N. R.; CHHABRA, A. Effectiveness and safety of daily versus alternate-day rosuvastatin dose in dyslipidemic patients: a prospective, randomized and open-label study. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 14, n. 1, p. 50–54, 2024. DOI: 10.18203/2319-2003.ijbcp20243835. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/5761. Acesso em: 23 oct. 2025.